GoKawiil
Tech News
A Nature piece argues that even well-designed drugs fail patients if they cannot reach the intended biological target effectively. The commentary highlights delivery mechanisms and targeting accuracy as critical, often underappreciated, factors in therapeutic success.
A Nature editorial argues that a substantial share of prescribed medicines fail to help patients simply because they are not taken as directed. It calls for more research and health-system attention on why patients skip or stop treatments, rather than focusing solely on drug development.
A Nature feature surveys six novel approaches under development for delivering drugs more precisely and effectively, ranging from advanced nanoparticle carriers to devices designed to target specific tissues. These innovations aim to overcome longstanding challenges such as poor bioavailability, degradation before reaching target sites, and off-target side effects.
Scientists are developing genetically modified bacteria designed to seek out and treat tumors from within the body. The approach relies on engineering microbes to recognize cancerous tissue and deliver therapeutic effects directly at the tumor site.
A new speculative fiction piece from Nature Futures follows Melba, an employee managing the Lost Luggage Department at a nearly abandoned interstellar flight headquarters. The story details how travelers' bags are shrunk via molecular-reduction technology before space voyages, and how some end up misrouted for decades, eventually landing in Melba's basement office filled with stacks of miniaturized suitcases.
Nature's careers team is organizing a 60-minute webinar examining how doctoral programmes are adjusting to the growing use of AI tools among graduate students, who increasingly rely on them for literature searches, coding, presentations and summarizing papers. Three panellists will discuss the benefits of AI in research alongside concerns that it may weaken essential skills PhD training is meant to instill.
Insilico Medicine's AI-designed drug rentosertib, originally developed to treat idiopathic pulmonary fibrosis, produced unexpected reductions in biological age markers during a phase 2a trial. Researchers reanalyzed blood samples from 42 of 71 Chinese trial participants using six computational aging clocks, finding treated patients showed younger predicted ages after 12 weeks compared to placebo recipients.
Google's research division ran an experiment rerouting a small subset of Google Maps drivers across 10 U.S. cities, including San Francisco, Los Angeles, Seattle and Chicago, spreading vehicles across more routes instead of funneling them onto the fastest-looking path. The published results, which appeared in Nature Cities, showed average speeds rose about 2% and travel times shortened by 0.7%, with highway-focused rerouting in Los Angeles boosting speeds by as much as 4.6%.
A Nature retrospective highlights the scientific career of William Thomson, later Lord Kelvin, noting that his contributions extended well beyond the temperature scale that bears his name. The piece surveys his broader body of work in physics and engineering during the 19th century.
An editorial in Nature argues that prediction markets allowing wagers on the outcomes of clinical trials pose risks to research integrity and public trust in science. It calls for limits on such betting activity to prevent interference with ongoing trials.
Responding to Ming Li's proposal to separate academic 'titles' from resource allocation in Chinese universities, a Nature correspondence argues the reform is unlikely to succeed. The author agrees that suppressed performance indicators tend to resurface under different labels, but contends university administrators benefit from the current metric-based system and thus have little incentive to change it.
A recent catastrophic flood event in Nepal illustrates how multiple climate-related hazards can combine to produce disasters far more severe than any single risk factor would suggest. Nature's commentary uses the event to argue that scientists and policymakers have been underestimating the danger posed by such compound risks.